Ulf Klein1, Nicole Heise. 1. aDepartment of Pathology & Cell Biology bDepartment of Microbiology & Immunology cHerbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: B-cell tumors originating from the transformation of germinal center B cells frequently harbor genetic mutations, leading to constitutive activation of the nuclear factor-κB (NF-κB) signaling pathway. The present review highlights recent insights into the roles of separate NF-κB transcription factors in germinal center B-cell development and discusses implications of the results for germinal center lymphomagenesis. RECENT FINDINGS: Understanding how aberrant NF-κB activation promotes tumorigenesis requires the understanding of the role of NF-κB in the tumor-precursor cells. Despite extensive knowledge on NF-κB biology, the function of this complex signaling pathway in the differentiation of germinal center B cells is largely unknown. The present review will discuss recent findings that revealed distinct roles of separate NF-κB transcription factors during the germinal center reaction in the context of germinal center lymphomagenesis. Most notably, a single NF-κB subunit, c-REL, was found to be required for the maintenance of the germinal center reaction and was associated with the activation of a metabolic program that promotes cell growth. SUMMARY: Identifying the biological roles of the separate NF-κB transcription factor subunits in germinal center biology will help to better understand the pathogenic consequences of their constitutive activation in B-cell tumors. This knowledge may be exploited for the development of targeted antitumor therapies aimed at inhibiting selectively those components of aberrant NF-κB activity which contribute to pathogenesis.
PURPOSE OF REVIEW: B-cell tumors originating from the transformation of germinal center B cells frequently harbor genetic mutations, leading to constitutive activation of the nuclear factor-κB (NF-κB) signaling pathway. The present review highlights recent insights into the roles of separate NF-κB transcription factors in germinal center B-cell development and discusses implications of the results for germinal center lymphomagenesis. RECENT FINDINGS: Understanding how aberrant NF-κB activation promotes tumorigenesis requires the understanding of the role of NF-κB in the tumor-precursor cells. Despite extensive knowledge on NF-κB biology, the function of this complex signaling pathway in the differentiation of germinal center B cells is largely unknown. The present review will discuss recent findings that revealed distinct roles of separate NF-κB transcription factors during the germinal center reaction in the context of germinal center lymphomagenesis. Most notably, a single NF-κB subunit, c-REL, was found to be required for the maintenance of the germinal center reaction and was associated with the activation of a metabolic program that promotes cell growth. SUMMARY: Identifying the biological roles of the separate NF-κB transcription factor subunits in germinal center biology will help to better understand the pathogenic consequences of their constitutive activation in B-cell tumors. This knowledge may be exploited for the development of targeted antitumor therapies aimed at inhibiting selectively those components of aberrant NF-κB activity which contribute to pathogenesis.
Authors: Jane Houldsworth; Adam B Olshen; Giorgio Cattoretti; Gerard B Donnelly; Julie Teruya-Feldstein; Jing Qin; Nallasivam Palanisamy; Yingjing Shen; Katerina Dyomina; Marina Petlakh; Qiulu Pan; Andrew D Zelenetz; Riccardo Dalla-Favera; R S K Chaganti Journal: Blood Date: 2003-11-13 Impact factor: 22.113
Authors: Kevin R Bushell; Yukyoung Kim; Fong Chun Chan; Susana Ben-Neriah; Andrew Jenks; Miguel Alcaide; Daniel Fornika; Bruno M Grande; Sarah Arthur; Randy D Gascoyne; Christian Steidl; Ryan D Morin Journal: Blood Date: 2014-12-02 Impact factor: 22.113
Authors: Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp Journal: Blood Date: 2003-08-21 Impact factor: 22.113
Authors: Thomas F E Barth; Josée I Martin-Subero; Stefan Joos; Christiane K Menz; Cornelia Hasel; Gunhild Mechtersheimer; Reza M Parwaresch; Peter Lichter; Reiner Siebert; Peter Möoller Journal: Blood Date: 2003-01-02 Impact factor: 22.113
Authors: Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt Journal: J Exp Med Date: 2003-09-15 Impact factor: 14.307
Authors: Angélica María Gamboa-Cedeño; Mariángeles Castillo; Wenming Xiao; Thomas A Waldmann; Stella Maris Ranuncolo Journal: J Cancer Res Clin Oncol Date: 2019-04-02 Impact factor: 4.553
Authors: Sara L Stone; Jessica N Peel; Christopher D Scharer; Christopher A Risley; Danielle A Chisolm; Michael D Schultz; Bingfei Yu; André Ballesteros-Tato; Wojciech Wojciechowski; Betty Mousseau; Ravi S Misra; Adedayo Hanidu; Huiping Jiang; Zhenhao Qi; Jeremy M Boss; Troy D Randall; Scott R Brodeur; Ananda W Goldrath; Amy S Weinmann; Alexander F Rosenberg; Frances E Lund Journal: Immunity Date: 2019-05-07 Impact factor: 31.745
Authors: Nilushi S De Silva; Michael M Anderson; Amanda Carette; Kathryn Silva; Nicole Heise; Govind Bhagat; Ulf Klein Journal: Proc Natl Acad Sci U S A Date: 2016-07-25 Impact factor: 11.205